Exelan Pharmaceuticals - Ownership and Business Overview


Exelan Pharmaceuticals Ownership

Who owns Exelan Pharmaceuticals?

Exelan Pharmaceuticals is owned by Cipla. It was acquired on September 3, 2015.

Exelan Pharmaceuticals Business Overview

Where is Exelan Pharmaceuticals headquartered?

Exelan Pharmaceuticals is headquartered in Lawrenceville, Georgia.

What sector is Exelan Pharmaceuticals in?

Exelan Pharmaceuticals is a distribution company.

When was Exelan Pharmaceuticals founded?

Exelan Pharmaceuticals was founded in 2012.

Distribution M&A Summary in 2015

Out of 60 sectors in the Mergr database, distribution ranked 9 in number of deals in 2015. The largest distribution acquisition in 2015 was MWI Veterinary Supply - which was acquired by Cencora for $2.5B.

Join Mergr to view all 334 acquisitions of distribution companies in 2015, including 46 acquisitions by private equity firms, and 288 by strategics.

Exelan Pharmaceuticals, Inc.

242 South Culver Street, Suite 208,
Lawrenceville, Georgia 30046
United States,
(678) 377-0405

Exelan Pharmaceuticals, Inc. is a sales and marketing company, with a focus on generic pharmaceuticals for the government and institutional market.

 Subscribe to unlock this and 203,558
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 4.6K Private Equity Firms
  • 195K M&A Transactions
  • 199K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 76K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.